Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Roche to share first Tecentriq trial results at ESMIO 2016

Roche to share first Tecentriq trial results at ESMIO 2016

3rd October 2016

Roche will be attending the European Society for Medical Oncology (ESMO) annual congress this week, where it will be sharing its latest cancer drug data.

From October 7th to 11th in Copenhagen, the company will be presenting results from studies of approved or investigational medicines spanning more than 20 cancer types, including the first pivotal phase III results for its new drug Tecentriq.

These superiority results from the phase III OAK study will compare Tecentriq to chemotherapy in a difficult-to-treat type of lung cancer, with the drug having met its co-primary endpoints in the trial.

Additionally, 19 abstracts featuring Tecentriq and other innovative molecules will be presented, including early data assessing Tecentriq in combination with Zelboraf and Cotellic in melanoma, and as a novel investigational combination with Cotellic in colorectal cancer.

Outcomes from early studies of cancer immunotherapy-based combinations will also be shared, alongside results from clinical studies of a broad range of Roche's investigational medicines and research into how different types of cancer affect people around the world.

Dr Sandra Horning, Roche's chief medical officer and head of global product development, said: "At Roche, our focus on understanding human immunology and cancer biology is helping us to develop new medicines that improve outcomes for people with cancer."

With over 20 years of experience within the pharmaceutical market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current pharmaceutical roles we have available, you can search for the latest job roles, register your details, or contact the team today.ADNFCR-8000103-ID-801826204-ADNFCR

We have hundreds of jobs available across the Healthcare industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.